SCHEMBL172347

SCHEMBL172347

CCCCN[C@@H](C)c1ccc2ccccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.49
KMT2A Q03164 2/20 0.49
CYP2D6 P10635 2/20 0.49
MEN1 O00255 1/20 0.49
TSHR P16473 1/20 0.49
HIF1A Q16665 1/20 0.49
UGT2B7 P16662 1/20 0.47
MMP9 P14780 1/20 0.47
CALM1 P0DP23 1/20 0.46
ALDH1A1 P00352 1/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 1/20 0.45
HDAC3 O15379 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
SIGMAR1 Q99720 2/20 0.43
CA2 P00918 1/20 0.43
CNR2 P34972 1/20 0.42
CASR P41180 2/20 0.41
CHRM2 P08172 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9522067 0.83 SIGMAR1 (0.64) CYP2D6SIGMAR1SLC6A2SLC6A4SLC6A3
SCHEMBL23330352 0.83 CYP2D6 (0.54) CYP1A2KMT2ACYP2D6MEN1TSHR
SCHEMBL13995506 0.82 CYP1A2 (0.50) CYP1A2KMT2ACYP2D6MEN1TSHR
SCHEMBL354251 0.80 MMP9 (0.47) CYP1A2KMT2ACYP2D6MEN1TSHR
SCHEMBL10232086 0.80 MMP9 (0.47) CYP1A2KMT2ACYP2D6MEN1TSHR
SCHEMBL354252 0.80 MMP9 (0.47) CYP1A2KMT2ACYP2D6MEN1TSHR
SCHEMBL13676409 0.79 CYP3A4 (0.63) CYP1A2KMT2ACYP2D6MEN1CALM1
SCHEMBL3384080 0.79 CYP3A4 (0.63) CYP1A2KMT2ACYP2D6MEN1CALM1
SCHEMBL13290808 0.78 CYP2D6 (0.53) CYP1A2KMT2ACYP2D6MEN1TSHR
SCHEMBL11865234 0.78 CYP2D6 (0.50) CYP1A2KMT2ACYP2D6MEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255738-B1 GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO NEUROCRINE BIOSCIENCES INC (US) 2012-03-07 EP disclosed